世界の白血病治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Leukemia Treatment Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15017 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、白血病治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。白血病治療薬の種類別市場規模（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ）、用途別市場規模（病院、研究所、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・白血病治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Pfizer、Novartis AG、Roche、Celgene、Biogen、Genzyme Corporation、Eisai C.、Bristol Myers Squibb Company (BMS) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ ・用途別分析2016年-2026年：病院、研究所、診断センター、その他 ・白血病治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・白血病治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・白血病治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・白血病治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・白血病治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Leukemia Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Leukemia Treatment Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Leukemia Treatment Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Leukemia Treatment Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Gleevec
Sapacitabine
GA101
Vasaroxine
Tosedosat
Revlimid
Bosutinib

Market segment by Application, can be divided into
Hospitals
Research Institutes
Diagnostic Centers
Others

Market segment by players, this report covers
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Leukemia Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Leukemia Treatment Drugs, with revenue, gross margin and global market share of Leukemia Treatment Drugs from 2019 to 2021.
Chapter 3, the Leukemia Treatment Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Leukemia Treatment Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Leukemia Treatment Drugs research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Leukemia Treatment Drugs
1.2 Classification of Leukemia Treatment Drugs by Type
1.2.1 Overview: Global Leukemia Treatment Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Leukemia Treatment Drugs Revenue Market Share by Type in 2020
1.2.3 Gleevec
1.2.4 Sapacitabine
1.2.5 GA101
1.2.6 Vasaroxine
1.2.7 Tosedosat
1.2.8 Revlimid
1.2.9 Bosutinib
1.3 Global Leukemia Treatment Drugs Market by Application
1.3.1 Overview: Global Leukemia Treatment Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global Leukemia Treatment Drugs Market Size & Forecast
1.5 Global Leukemia Treatment Drugs Market Size and Forecast by Region
1.5.1 Global Leukemia Treatment Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Leukemia Treatment Drugs Market Size by Region, (2016-2021)
1.5.3 North America Leukemia Treatment Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Leukemia Treatment Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Leukemia Treatment Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Leukemia Treatment Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Leukemia Treatment Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Leukemia Treatment Drugs Market Drivers
1.6.2 Leukemia Treatment Drugs Market Restraints
1.6.3 Leukemia Treatment Drugs Trends Analysis
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Leukemia Treatment Drugs Product and Solutions
2.1.4 GSK Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GSK Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Leukemia Treatment Drugs Product and Solutions
2.2.4 Pfizer Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Leukemia Treatment Drugs Product and Solutions
2.3.4 Novartis AG Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Leukemia Treatment Drugs Product and Solutions
2.4.4 Roche Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Leukemia Treatment Drugs Product and Solutions
2.5.4 Celgene Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Recent Developments and Future Plans
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Leukemia Treatment Drugs Product and Solutions
2.6.4 Biogen Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biogen Recent Developments and Future Plans
2.7 Genzyme Corporation
2.7.1 Genzyme Corporation Details
2.7.2 Genzyme Corporation Major Business
2.7.3 Genzyme Corporation Leukemia Treatment Drugs Product and Solutions
2.7.4 Genzyme Corporation Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Genzyme Corporation Recent Developments and Future Plans
2.8 Eisai C.
2.8.1 Eisai C. Details
2.8.2 Eisai C. Major Business
2.8.3 Eisai C. Leukemia Treatment Drugs Product and Solutions
2.8.4 Eisai C. Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eisai C. Recent Developments and Future Plans
2.9 Bristol Myers Squibb Company (BMS)
2.9.1 Bristol Myers Squibb Company (BMS) Details
2.9.2 Bristol Myers Squibb Company (BMS) Major Business
2.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product and Solutions
2.9.4 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bristol Myers Squibb Company (BMS) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Leukemia Treatment Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Leukemia Treatment Drugs Players Market Share
3.2.2 Top 10 Leukemia Treatment Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Leukemia Treatment Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Leukemia Treatment Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Leukemia Treatment Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Leukemia Treatment Drugs Revenue Market Share by Application (2016-2021)
5.2 Leukemia Treatment Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Leukemia Treatment Drugs Revenue by Type (2016-2026)
6.2 North America Leukemia Treatment Drugs Revenue by Application (2016-2026)
6.3 North America Leukemia Treatment Drugs Market Size by Country
6.3.1 North America Leukemia Treatment Drugs Revenue by Country (2016-2026)
6.3.2 United States Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Leukemia Treatment Drugs Revenue by Type (2016-2026)
7.2 Europe Leukemia Treatment Drugs Revenue by Application (2016-2026)
7.3 Europe Leukemia Treatment Drugs Market Size by Country
7.3.1 Europe Leukemia Treatment Drugs Revenue by Country (2016-2026)
7.3.2 Germany Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
7.3.3 France Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Leukemia Treatment Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Leukemia Treatment Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Region
8.3.1 Asia-Pacific Leukemia Treatment Drugs Revenue by Region (2016-2026)
8.3.2 China Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8.3.5 India Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Leukemia Treatment Drugs Revenue by Type (2016-2026)
9.2 South America Leukemia Treatment Drugs Revenue by Application (2016-2026)
9.3 South America Leukemia Treatment Drugs Market Size by Country
9.3.1 South America Leukemia Treatment Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Leukemia Treatment Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Leukemia Treatment Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Country
10.3.1 Middle East & Africa Leukemia Treatment Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Leukemia Treatment Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Leukemia Treatment Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Leukemia Treatment Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Leukemia Treatment Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Leukemia Treatment Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Leukemia Treatment Drugs Revenue Market Share by Region (2021-2026)
Table 6. GSK Corporate Information, Head Office, and Major Competitors
Table 7. GSK Major Business
Table 8. GSK Leukemia Treatment Drugs Product and Solutions
Table 9. GSK Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Leukemia Treatment Drugs Product and Solutions
Table 13. Pfizer Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 15. Novartis AG Major Business
Table 16. Novartis AG Leukemia Treatment Drugs Product and Solutions
Table 17. Novartis AG Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Leukemia Treatment Drugs Product and Solutions
Table 21. Roche Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Major Business
Table 24. Celgene Leukemia Treatment Drugs Product and Solutions
Table 25. Celgene Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Biogen Corporate Information, Head Office, and Major Competitors
Table 27. Biogen Major Business
Table 28. Biogen Leukemia Treatment Drugs Product and Solutions
Table 29. Biogen Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Genzyme Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Genzyme Corporation Major Business
Table 32. Genzyme Corporation Leukemia Treatment Drugs Product and Solutions
Table 33. Genzyme Corporation Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eisai C. Corporate Information, Head Office, and Major Competitors
Table 35. Eisai C. Major Business
Table 36. Eisai C. Leukemia Treatment Drugs Product and Solutions
Table 37. Eisai C. Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bristol Myers Squibb Company (BMS) Corporate Information, Head Office, and Major Competitors
Table 39. Bristol Myers Squibb Company (BMS) Major Business
Table 40. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product and Solutions
Table 41. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Leukemia Treatment Drugs Revenue (USD Million) by Players (2019-2021)
Table 43. Global Leukemia Treatment Drugs Revenue Share by Players (2019-2021)
Table 44. Breakdown of Leukemia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Leukemia Treatment Drugs Players Head Office, Products and Services Provided
Table 46. Leukemia Treatment Drugs Mergers & Acquisitions in the Past Five Years
Table 47. Leukemia Treatment Drugs New Entrants and Expansion Plans
Table 48. Global Leukemia Treatment Drugs Revenue (USD Million) by Type (2016-2021)
Table 49. Global Leukemia Treatment Drugs Revenue Share by Type (2016-2021)
Table 50. Global Leukemia Treatment Drugs Revenue Forecast by Type (2021-2026)
Table 51. Global Leukemia Treatment Drugs Revenue by Application (2016-2021)
Table 52. Global Leukemia Treatment Drugs Revenue Forecast by Application (2021-2026)
Table 53. North America Leukemia Treatment Drugs Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Leukemia Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Leukemia Treatment Drugs Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Leukemia Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Leukemia Treatment Drugs Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Leukemia Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Leukemia Treatment Drugs Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Leukemia Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Leukemia Treatment Drugs Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Leukemia Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Leukemia Treatment Drugs Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Leukemia Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Leukemia Treatment Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Leukemia Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Leukemia Treatment Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Leukemia Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Leukemia Treatment Drugs Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Leukemia Treatment Drugs Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Leukemia Treatment Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Leukemia Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Leukemia Treatment Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Leukemia Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Leukemia Treatment Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Leukemia Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Leukemia Treatment Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Leukemia Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Leukemia Treatment Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Leukemia Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Leukemia Treatment Drugs Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Leukemia Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Leukemia Treatment Drugs Picture
Figure 2. Global Leukemia Treatment Drugs Revenue Market Share by Type in 2020
Figure 3. Gleevec
Figure 4. Sapacitabine
Figure 5. GA101
Figure 6. Vasaroxine
Figure 7. Tosedosat
Figure 8. Revlimid
Figure 9. Bosutinib
Figure 10. Leukemia Treatment Drugs Revenue Market Share by Application in 2020
Figure 11. Hospitals Picture
Figure 12. Research Institutes Picture
Figure 13. Diagnostic Centers Picture
Figure 14. Others Picture
Figure 15. Global Leukemia Treatment Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Leukemia Treatment Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Leukemia Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 18. Global Leukemia Treatment Drugs Revenue Market Share by Region in 2020
Figure 19. North America Leukemia Treatment Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Leukemia Treatment Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Leukemia Treatment Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Leukemia Treatment Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Leukemia Treatment Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Leukemia Treatment Drugs Market Drivers
Figure 25. Leukemia Treatment Drugs Market Restraints
Figure 26. Leukemia Treatment Drugs Market Trends
Figure 27. GSK Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Novartis AG Recent Developments and Future Plans
Figure 30. Roche Recent Developments and Future Plans
Figure 31. Celgene Recent Developments and Future Plans
Figure 32. Biogen Recent Developments and Future Plans
Figure 33. Genzyme Corporation Recent Developments and Future Plans
Figure 34. Eisai C. Recent Developments and Future Plans
Figure 35. Bristol Myers Squibb Company (BMS) Recent Developments and Future Plans
Figure 36. Global Leukemia Treatment Drugs Revenue Share by Players in 2020
Figure 37. Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Leukemia Treatment Drugs Revenue Market Share in 2020
Figure 39. Global Top 10 Players Leukemia Treatment Drugs Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Leukemia Treatment Drugs Revenue Share by Type in 2020
Figure 42. Global Leukemia Treatment Drugs Market Share Forecast by Type (2021-2026)
Figure 43. Global Leukemia Treatment Drugs Revenue Share by Application in 2020
Figure 44. Global Leukemia Treatment Drugs Market Share Forecast by Application (2021-2026)
Figure 45. North America Leukemia Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 46. North America Leukemia Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 47. North America Leukemia Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 48. United States Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Leukemia Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 52. Europe Leukemia Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 53. Europe Leukemia Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 54. Germany Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Leukemia Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Leukemia Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Leukemia Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 62. China Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Leukemia Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Leukemia Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Leukemia Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Leukemia Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Leukemia Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Leukemia Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Leukemia Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

---